LYEL icon

Lyell Immunopharma

113 hedge funds and large institutions have $81.8M invested in Lyell Immunopharma in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 7 closing their positions.

Holders
113
Holders Change
+8
Holders Change %
+7.62%
% of All Funds
1.54%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
16
Increased
23
Reduced
36
Closed
7
Calls
$2K
Puts
$3K
Net Calls
-$1K
Net Calls Change
-$2K
Name Market Value Shares Shares
Change
Shares
Change %
MM
1
MWG Management
British Virgin Islands
$10.8M 20,162,332
FCMI
2
Foresite Capital Management IV
California
$8.61M 16,007,999 +7,682,999 +92%
OPL
3
Orland Properties Ltd
British Virgin Islands
$8.15M 15,093,969
BlackRock
4
BlackRock
New York
$6.84M 12,721,571 -544,298 -4%
DC
5
Decheng Capital
California
$6.41M 11,909,341
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.24M 9,737,729 -28,354 -0.3%
FCMV
7
Foresite Capital Management V
California
$4.38M 8,133,047
VP
8
venBio Partners
California
$3.82M 7,102,190
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$3.49M 6,478,836 -431,913 -6%
AI
10
Alphabet Inc
California
$3.17M 5,865,125
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.37M 4,399,139 +261,875 +6%
Citadel Advisors
12
Citadel Advisors
Florida
$2.35M 4,506,857 +752,112 +20%
State Street
13
State Street
Massachusetts
$1.99M 3,702,440 -46,233 -1%
HH
14
HSG Holding
Hong Kong
$1.46M 3,045,997
AC
15
Almitas Capital
California
$1.34M 2,482,606 +1,432,086 +136%
Renaissance Technologies
16
Renaissance Technologies
New York
$951K 1,768,500 +156,354 +10%
MCMU
17
MIC Capital Management (UK)
United Kingdom
$936K 1,740,569
Charles Schwab
18
Charles Schwab
California
$863K 1,604,676 -41,111 -2%
Northern Trust
19
Northern Trust
Illinois
$697K 1,295,073 -15,151 -1%
TD Asset Management
20
TD Asset Management
Ontario, Canada
$540K 1,004,642
IC
21
Ikarian Capital
Texas
$471K 876,037 -400,000 -31%
Morgan Stanley
22
Morgan Stanley
New York
$466K 866,403 -347,884 -29%
JJ
23
Johnson & Johnson
New Jersey
$443K 823,317
TPC
24
Takeda Pharmaceutical Company
Japan
$443K 823,317
Acadian Asset Management
25
Acadian Asset Management
Massachusetts
$354K 660,899 +443,614 +204%